‘‘SEC. 317U. SYNTHETIC RECREATIONAL DRUGS. 
‘‘(a) STUDY.—Not later than 1 year after the date 
of enactment of the Synthetic Drug Prevention, Treat-
ment, and Education Act, the Director of the Centers for 
Disease Control and Prevention (in this section referred 
to as the ‘Director’) shall— 
‘‘(1) complete a study on strategies for pre-
venting and treating the use of synthetic recreational 
drugs (as identified pursuant to subsection (b)(3)), 
including best rehabilitation practices; and 
‘‘(2) submit a report to the Congress on the re-
sults of such study. 
‘‘(b) DATABASE.— 
‘‘(1) IN GENERAL.—The Secretary, in coordina-
tion with the Administrator of the Drug Enforce-
ment Administration, shall establish and maintain a 
database of synthetic recreational drugs. 
‘‘(2) AVAILABILITY.—The Secretary shall make 
the information in the database under paragraph (1) 
publicly available for use in preventing and treating 
the use of synthetic recreational drugs. 
‘‘(3) IDENTIFICATION
OF
SYNTHETIC
REC-
REATIONAL DRUGS.—Beginning not later than 90 
days after the date of the enactment of the Syn-
thetic Drug Prevention, Treatment, and Education 
Act, for purposes of this section, the Secretary shall 
VerDate Sep 11 2014 
03:26 Jun 17, 2017
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2900.IH
H2900
rfrederick on DSK3GLQ082PROD with BILLS
specify (and update as necessary) a list of sub-
stances, each of which shall satisfy the following cri-
teria: 
‘‘(A) The substance is an analogue of a 
controlled substance (as defined in section 102 
of the Controlled Substances Act). 
‘‘(B) The substance is not marketed as a 
drug (as defined in section 201 of the Federal 
Food, Drug, and Cosmetic Act). 
‘‘(C) The substance is determined by the 
Secretary to be marketed for recreational 
human use, irrespective of claims to the con-
trary in the labeling and promotion of the sub-
stance. 
Each substance identified on the most recent list 
specified by the Secretary pursuant to this para-
graph is referred to in this section as a ‘synthetic 
recreational drug’. 
‘‘(c) CANNABIMIMETIC AGENTS.— 
‘‘(1) OUTREACH CAMPAIGN.—Not later than 1 
year after the date of enactment of the Synthetic 
Drug Prevention, Treatment, and Education Act, 
the Director, in collaboration with the Assistant Sec-
retary for Mental Health and Substance Use, the 
Director of the National Institute on Drug Abuse, 
VerDate Sep 11 2014 
03:26 Jun 17, 2017
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2900.IH
H2900
rfrederick on DSK3GLQ082PROD with BILLS
the Director of the National Institutes of Health, 
and the Administrator of the Drug Enforcement Ad-
ministration, shall develop and implement a national 
outreach campaign to educate law enforcement per-
sonnel, State and local agencies, health care profes-
sionals, community health organizations, parents, 
youth, and other community members about pre-
venting and treating the use of cannabimimetic 
agents. 
‘‘(2) GRANTS.— 
‘‘(A) IN
GENERAL.—The Director may 
make grants to Federally-qualified health cen-
ters for programs to increase public awareness 
about, and prevent and treat, the use of 
cannabimimetic agents. 
‘‘(B) PARTNERSHIP.—A Federally-quali-
fied health center receiving a grant under sub-
paragraph (A) for a program, may, to the ex-
tent such program is with respect to increasing 
awareness about, or preventing, the use of 
cannabimimetic agents, partner with a recipient 
of grant under section 1032 of the National 
Narcotics Leadership Act of 1988 (21 U.S.C. 
1532) to carry out such elements of the pro-
gram. 
VerDate Sep 11 2014 
03:26 Jun 17, 2017
Jkt 069200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H2900.IH
H2900
rfrederick on DSK3GLQ082PROD with BILLS
‘‘(C) MAXIMUM AMOUNT.—The maximum 
amount of a grant under this section shall be 
$250,000. 
‘‘(D) 
AUTHORIZATION
OF
APPROPRIA-
TIONS.—To carry out this paragraph, there is 
authorized to be appropriated $5,000,000 for 
the period of fiscal years 2018 through 2020. 
‘‘(d) DEFINITIONS.—In this section: 
‘‘(1) The term ‘cannabimimetic agent’ has the 
meaning given to that term in section 202(d)(2) of 
the Controlled Substances Act. 
‘‘(2) The term ‘Federally-qualified health cen-
ter’ has the meaning given to such term in section 
1861(aa) of the Social Security Act.’’. 
Æ 
VerDate Sep 11 2014 
03:26 Jun 17, 2017
Jkt 069200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H2900.IH
H2900
rfrederick on DSK3GLQ082PROD with BILLS